Relative Strength Chart Perspective Therapeutics, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 18:08:33 03/08/2026 +03			5-day change	1st Jan Change
2.990 ^USD	+2.75%		+6.21%	+8.91%

07-28	Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation	MT
07-17	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	PERSPECTIVE THERAPEUTICS, INC.	Other Biotechnology & Medical Research	+2.23%	0.00%	+5.82%	-20.92%	-58.12%	332M